DESOGESTREL AND ETHINYL ESTRADIOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Desogestrel And Ethinyl Estradiol, and when can generic versions of Desogestrel And Ethinyl Estradiol launch?
Desogestrel And Ethinyl Estradiol is a drug marketed by Duramed Pharms Barr, Dr Reddys Labs Sa, Naari Pte Ltd, Novast Labs, Watson Labs, and Xiromed. and is included in nine NDAs.
The generic ingredient in DESOGESTREL AND ETHINYL ESTRADIOL is desogestrel; ethinyl estradiol. There are eight drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the desogestrel; ethinyl estradiol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Desogestrel And Ethinyl Estradiol
A generic version of DESOGESTREL AND ETHINYL ESTRADIOL was approved as desogestrel; ethinyl estradiol by DURAMED PHARMS BARR on August 12th, 1999.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DESOGESTREL AND ETHINYL ESTRADIOL?
- What are the global sales for DESOGESTREL AND ETHINYL ESTRADIOL?
- What is Average Wholesale Price for DESOGESTREL AND ETHINYL ESTRADIOL?
Summary for DESOGESTREL AND ETHINYL ESTRADIOL
US Patents: | 0 |
Applicants: | 6 |
NDAs: | 9 |
Finished Product Suppliers / Packagers: | 8 |
Raw Ingredient (Bulk) Api Vendors: | 4 |
Clinical Trials: | 7 |
Patent Applications: | 217 |
DailyMed Link: | DESOGESTREL AND ETHINYL ESTRADIOL at DailyMed |
Recent Clinical Trials for DESOGESTREL AND ETHINYL ESTRADIOL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Laboratorios Andromaco S.A. | Phase 1 |
National Institutes of Health (NIH) | Phase 3 |
University of Pennsylvania | Phase 3 |